Citations (35)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Seda Colak, Emre Tekgoz, Muhammet Cinar & Sedat Yilmaz. (2021) The assessment of tocilizumab therapy on recurrent attacks of patients with familial Mediterranean fever: A retrospective study of 15 patients. Modern Rheumatology 31:1, pages 223-225.
Read now
Read now
Articles from other publishers (34)
Thomas W. Weickert, Isabella Jacomb, Rhoshel Lenroot, Julia Lappin, Danielle Weinberg, William S. Brooks, David Brown, Daniel Pellen, Jochen Kindler, Adith Mohan, Denis Wakefield, Andrew R. Lloyd, Clive Stanton, Maryanne O'Donnell, Dennis Liu, Cherrie Galletly & Cynthia Shannon Weickert. (2024) Adjunctive canakinumab reduces peripheral inflammation markers and improves positive symptoms in people with schizophrenia and inflammation: A randomized control trial. Brain, Behavior, and Immunity 115, pages 191-200.
Crossref
Crossref
Andrea Angeletti, Maurizio Bruschi, Xhuliana Kajana, Edoardo La Porta, Sonia Spinelli, Gianluca Caridi, Francesca Lugani, Enrico Eugenio Verrina & Gian Marco Ghiggeri. (2023) Biologics in steroid resistant nephrotic syndrome in childhood: review and new hypothesis-driven treatment. Frontiers in Immunology 14.
Crossref
Crossref
Ufuk İlgen, İsmail Uçar, Güner Kılıç & Orhan Küçükşahin. (2023) AA amyloidosis of unknown aetiology: response to treatment with interleukin-1 inhibitors. Clinical Kidney Journal 16:6, pages 1038-1042.
Crossref
Crossref
Sabine Karam, Mohamad Haidous, Virginie Royal & Nelson Leung. (2023) Renal AA amyloidosis: presentation, diagnosis, and current therapeutic options: a review. Kidney International 103:3, pages 473-484.
Crossref
Crossref
Haruki Matsumoto, Kenji Saito, Yuya Sumichika, Shuhei Yoshida, Jumpei Temmoku, Yuya Fujita, Naoki Matsuoka, Tomoyuki Asano, Shuzo Sato & Kiyoshi Migita. (2023) Atypical Familial Mediterranean Fever Presenting with Recurrent Upper Back Pain: A Case Report. The Tohoku Journal of Experimental Medicine 260:2, pages 165-169.
Crossref
Crossref
S. Salah, H. Lotfy, M. H. Abu-Zaid, M. El Gaafary, H. Abdulhady, H. Salah, E. Abd El-Latif, Y. Farag, M. Eissa, S. Esam Maher, A. Radwan, Amira T. El-Shanawany, B. M. Medhat, D. El Mikkawy, D. M. Mosa, G. El Deriny, M. Mortada, N. S. Osman, N. A. Fouad, N. E. Elkaraly, S. S. Mohamed, S. A. Tabra, W. A. Hassan, Y. Amer, S. I. Nasef & Y. El Miedany. (2022) Egyptian evidence-based consensus on clinical practice recommendations for the management of familial Mediterranean fever. Egyptian Rheumatology and Rehabilitation 49:1.
Crossref
Crossref
B H Egeli & S Ugurlu. (2022) Familial Mediterranean fever: clinical state of the art. QJM: An International Journal of Medicine 115:11, pages 711-718.
Crossref
Crossref
Eugenio Sangiorgi & Donato Rigante. (2022) The Clinical Chameleon of Autoinflammatory Diseases in Children. Cells 11:14, pages 2231.
Crossref
Crossref
Takahiro Itamiya, Toshihiko Komai, Hiroko Kanda, Yasuo Nagafuchi, Hyangri Chang, Shota Shibata, Hiroyuki Ishiura, Hirofumi Shoda, Tatsushi Toda & Keishi Fujio. (2022) Efficacy of canakinumab on AA amyloidosis in late-onset NLRP3-associated autoinflammatory disease with an I574F somatic mosaic mutation. Clinical Rheumatology 41:7, pages 2233-2237.
Crossref
Crossref
Eitan Giat, Ilan Ben-Zvi, Merav Lidar & Avi Livneh. (2022) The Preferential Use of Anakinra in Various Settings of FMF: A Review Applied to an Updated Treatment-Related Perspective of the Disease. International Journal of Molecular Sciences 23:7, pages 3956.
Crossref
Crossref
Andrea Angeletti, Alberto Magnasco, AntonellaTrivelli, Ludovica M. Degl’Innocenti, Giorgio Piaggio, Francesca Lugani, Gianluca Caridi, Enrico Verrina, Paolo Cravedi & Gian Marco Ghiggeri. (2022) Refractory Minimal Change Disease and Focal Segmental Glomerular Sclerosis Treated With Anakinra. Kidney International Reports 7:1, pages 121-124.
Crossref
Crossref
Caroline Vinit, Sophie Georgin-Lavialle, Aikaterini Theodoropoulou, Catherine Barbier, Alexandre Belot, Manel Mejbri, Pascal Pillet, Jana Pachlopnik, Sylvaine Poignant, Charlotte Rebelle, Andreas Woerner, Isabelle Koné-Paut & Véronique Hentgen. (2021) Real-Life Indications of Interleukin-1 Blocking Agents in Hereditary Recurrent Fevers: Data From the JIRcohort and a Literature Review. Frontiers in Immunology 12.
Crossref
Crossref
Tolga Yildirim, Rahmi Yilmaz, Arzu Saglam, Muge Uzerk-Kibar, Jabrayil Jabrayilov & Yunus Erdem. (2021) Baseline renal functions predict the effect of canakinumab on regression of proteinuria in patients with familial Mediterranean fever. Nefrología (English Edition) 41:6, pages 632-639.
Crossref
Crossref
Tolga Yildirim, Rahmi Yilmaz, Arzu Saglam, Muge Uzerk-Kibar, Jabrayil Jabrayilov & Yunus Erdem. (2021) Baseline renal functions predict the effect of canakinumab on regression of proteinuria in patients with familial Mediterranean fever. Nefrología 41:6, pages 632-639.
Crossref
Crossref
Rossella Siligato, Guido Gembillo, Vincenzo Calabrese, Giovanni Conti & Domenico Santoro. (2021) Amyloidosis and Glomerular Diseases in Familial Mediterranean Fever. Medicina 57:10, pages 1049.
Crossref
Crossref
Veli Yazısız, Vural Taner Yılmaz, İsmail Uçar, Özgür Dandin, Bengisu Aslan, Funda Erbasan, Hüseyin Koçak & Mustafa Ender Terzioğlu. (2021) The use of anti-interleukin-1 agents and tumor necrosis factor‐alpha inhibitors in renal transplant recipients. Archives of Rheumatology 36:3, pages 366-374.
Crossref
Crossref
Olga L Kukuy, Pazit Beckerman, Dganit Dinour, Ilan Ben-Zvi & Avi Livneh. (2021) Amyloid storm: acute kidney injury and massive proteinuria, rapidly progressing to end-stage kidney disease in AA amyloidosis of familial Mediterranean fever. Rheumatology 60:7, pages 3235-3242.
Crossref
Crossref
Haruki Matsumoto, Yuya Fujita, Tomoyuki Asano, Shuzo Sato, Jumpei Temmoku, Makiko Yashiro-Furuya, Naoki Matsuoka, Hiroshi Watanabe, Eiji Suzuki & Kiyoshi Migita. (2021) An unusual case of familial Mediterranean fever complicated with protracted peritonitis. Medicine: Case Reports and Study Protocols 2:5, pages e0105.
Crossref
Crossref
Zahra Bahari, Zohreh Jangravi, Hassan Ghoshooni, Mohammad Reza Afarinesh & Gholam Hossein Meftahi. (2021) Pharmacological mechanism of immunomodulatory agents for the treatment of severe cases of COVID-19 infection. Inflammation Research 70:4, pages 389-405.
Crossref
Crossref
Tatjana Welzel, Susanne M. Benseler & Jasmin B. Kuemmerle-Deschner. (2021) Management of Monogenic IL-1 Mediated Autoinflammatory Diseases in Childhood. Frontiers in Immunology 12.
Crossref
Crossref
Isabelle Koné-Paut & Perrine Dusser. (2020) How to handle the main drugs to treat autoinflammatory disorders and how we treat common autoinflammatory diseases. Giornale Italiano di Dermatologia e Venereologia 155:5.
Crossref
Crossref
Ali Şahin, Mehmet Emin Derin, Fatih Albayrak, Burak Karakaş & Yalçın Karagöz. (2020) Assessment of effectiveness of anakinra and canakinumab in patients with colchicine-resistant/unresponsive familial Mediterranean fever. Advances in Rheumatology 60:1.
Crossref
Crossref
Serdal Ugurlu, Bilgesu Ergezen, Bugra Han Egeli, Oguzhan Selvi & Huri Ozdogan. (2020) Safety and efficacy of anti-interleukin-1 treatment in 40 patients, followed in a single centre, with AA amyloidosis secondary to familial Mediterranean fever. Rheumatology 59:12, pages 3892-3899.
Crossref
Crossref
Andrea Angeletti, Chiara Cantarelli, Astgik Petrosyan, Sofia Andrighetto, Kelly Budge, Vivette D. D’Agati, Susan Hartzell, Deborah Malvi, Chiara Donadei, Joshua M. Thurman, Danica Galešić-Ljubanović, John Cijiang He, Wenzhen Xiao, Kirk N. Campbell, Jenny Wong, Clara Fischman, Joaquin Manrique, Gianluigi Zaza, Enrico Fiaccadori, Gaetano La Manna, Miguel Fribourg, Jeremy Leventhal, Stefano Da Sacco, Laura Perin, Peter S. Heeger & Paolo Cravedi. (2020) Loss of decay-accelerating factor triggers podocyte injury and glomerulosclerosis. Journal of Experimental Medicine 217:9.
Crossref
Crossref
Mehmet Soy, Gökhan Keser, Pamir Atagündüz, Fehmi Tabak, Işık Atagündüz & Servet Kayhan. (2020) Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment. Clinical Rheumatology 39:7, pages 2085-2094.
Crossref
Crossref
Véronique Hentgen, Caroline Vinit, Antoine Fayand & Sophie Georgin-Lavialle. (2020) The Use of Interleukine-1 Inhibitors in Familial Mediterranean Fever Patients: A Narrative Review. Frontiers in Immunology 11.
Crossref
Crossref
R. E. Yakubtsevich. (2020) BLOCKADE OF THE CYTOKINE STORM IN SEVERE SARS-COV-2 INFECTION: DRUG SUPPRESSION OR EXTRACORPOREAL ELIMINATION?. Journal of the Grodno State Medical University 18:5, pages 505-512.
Crossref
Crossref
Judith Kelsen & Kaan Boztug. 2020. Stiehm's Immune Deficiencies. Stiehm's Immune Deficiencies
721
735
.
Nuh Atas, Berkan Armagan, Erdal Bodakci, Hasan Satis, Alper Sari, Nazife Sule Yasar Bilge, Reyhan Bilici Salman, Gozde Kubra Yardımcı, Hakan Babaoglu, Levent Kilic, Mehmet Akif Ozturk, Berna Goker, Seminur Haznedaroglu, Timucin Kasifoglu, Umut Kalyoncu & Abdurrahman Tufan. (2019) Familial Mediterranean fever-associated infertility and underlying factors. Clinical Rheumatology 39:1, pages 255-261.
Crossref
Crossref
Georges El Hasbani, Ali Jawad & Imad Uthman. (2019) Update on the management of colchicine resistant Familial Mediterranean Fever (FMF). Orphanet Journal of Rare Diseases 14:1.
Crossref
Crossref
David E. Place & Thirumala-Devi Kanneganti. (2019) Cell death–mediated cytokine release and its therapeutic implications. Journal of Experimental Medicine 216:7, pages 1474-1486.
Crossref
Crossref
Ozkan Varan, Hamit Kucuk, Hakan Babaoglu, Nuh Atas, Reyhan Bilici Salman, Hasan Satis, Mehmet Akif Ozturk, Seminur Haznedaroglu, Berna Goker & Abdurrahman Tufan. (2018) Effect of interleukin-1 antagonists on the quality of life in familial Mediterranean fever patients. Clinical Rheumatology 38:4, pages 1125-1130.
Crossref
Crossref
Mikhail M. Kostik, Olga V. Zhogova, Natalia V. Lagunova, Sergey V. Ivanovskiy, Oksana L. Kolobova & Larisa N. Melnikova. (2018) Familial Mediterranean Fever: Current Approaches to Diagnosis and Treatment. Current pediatrics 17:5, pages 371-380.
Crossref
Crossref
Sinan Trabulus, Merve Korkmaz, Eda Kaya & Nurhan Seyahi. (2018) Canakinumab treatment in kidney transplant recipients with AA amyloidosis due to familial Mediterranean fever. Clinical Transplantation 32:8.
Crossref
Crossref